Finally, CIMAVAX‐EGF is a Cuban‐developed epidermal growth factor (EGF)‐bacterial fusion protein vaccine adjuvanted with Montanide ISA‐51 for the treatment of NSCLC. This evidence concerns the gene EGF and non-small cell lung carcinoma.